Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
Shire’s SHP609 receives FDA fast track designation for treatment of Hunter syndrome
Shire announced the FDA has granted Fast Track designation for SHP609 (idursulfase-IT; also known as HGT-2310) for treatment of neurocognitive decline associated with Hunter syndrome (mucopolysaccharidosis II or MPSII).
January 26, 2015
More...
Email This Page
to a Friend
Print This
Page